EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
Cancer patients receiving drugs to lower the risk of anaemia may be...
Published Tuesday 01 December 2009
Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have undergone chemotherapy....
Published Tuesday 01 December 2009
Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a regular basis...
Published Monday 30 November 2009
Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more likely to...
Published Sunday 29 November 2009
Number of Americans with diabetes expected to double by 2034
The number of people developing diabetes in the US is expected to...
Published Sunday 29 November 2009
H1N1 virus appears to increase asthma risk in children
Asthma is a significant risk factor in children who have contracted the...
Published Sunday 29 November 2009
New treatment could prevent thrombosis in PAD patients
Thrombosis is a common side effect in patients undergoing bypass surgery for...
Published Sunday 29 November 2009
Brazilian mint shown to combat pain
Patients experiencing chronic pain may benefit from Hyptis crenata, also known as...
Published Wednesday 25 November 2009
Chronic pain a risk factor for falls
Individuals experiencing chronic pain may be more likely to experience a fall...
Published Wednesday 25 November 2009
Fewer US hepatitis C patients receiving antiviral therapy
The number of hepatitis C (HCV) patients receiving antiviral therapy in the...
Published Tuesday 24 November 2009
Discovery could lead to improved non-Hodgkin's lymphoma treatment
Researchers in the US have discovered a new molecular mechanism which could...
Published Monday 23 November 2009
LDL cholesterol levels on the decline in the US
The number of adults with high levels of LDLcholesterol in the US...
Published Saturday 21 November 2009
Erectile dysfunction drug can benefit heart disease patients
A drug used for men with erectile dysfunction has been found to...
Published Thursday 19 November 2009
More Medical News
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Antifungal-antibacterials (imidazole antifungals).
Miconazole nitrate
Each pessary contains 100 mg miconazole nitrate
Vaginal pessaries. The pessaries are white to beige coloured and egg-shaped
For the local treatment of vulvovaginal candidosis and superinfections due to gram-positive bacteria.
Gyno-Daktarin pessaries are for vaginal administration.
Adults and elderly
One pessary to be inserted deeply into the vagina. This is best done in the reclining position. Repeat this procedure once daily for 14 days or 1 pessary twice daily for 7 days. Continue the course of treatment, even after pruritus and leukorrhoea have disappeared or menstruation begins.
Not applicable.
Gyno-Daktarin pessaries are contraindicated in individuals with a known hypersensitivity to miconazole or another ingredient of the pessaries.
Should local sensitisation or an allergic reaction occur, treatment should be discontinued.
Appropriate therapy is indicated when the sexual partner is also infected.
Gyno-Daktarin pessaries do not stain skin or clothes.
The concurrent use of latex condoms or diaphragms with vaginal anti-infective preparations may decrease the effectiveness of latex contraceptive agents. Therefore Gyno-Daktarin pessaries should not be used concurrently with a latex condom or latex diaphragm.
Miconazole administered systemically is known to inhibit CYP3A4/2C9. Due to the limited systemic availability after vaginal application, clinically relevant interactions occur very rarely. In patients on oral anticoagulants, such as warfarin, caution should be exercised and anticoagulant effect should be monitored. The effects and side effects of other drugs metabolized by CYP2C9 (e.g.,oral hypoglycemics and phenytoin) and also CYP3A4 (e.g., HMG-CoA reductase inhibitors such as simvastatin and lovastatin and calcium channel blockers such as dihydropyridines and verapamil), when co-administered with miconazole, can be increased and caution should be exercised.
Contact should be avoided between certain latex products such as contraceptive diaphragms or condoms and Gyno-Daktarin pessaries since the constituents may be damage the latex.
Adverse reactions are rare and are mild in most cases.
Most frequently reported were local irritation, pruritus and burning sensation, especially at the start of treatment. Complaints of pelvic cramps, hives, skin rash have also been reported.
Janssen-Cilag Ltd
(POM)
14 May 2009









